{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:34Z","timestamp":1786993714440,"version":"build-2736575974"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.lfs.2022.120709","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:38:39Z","timestamp":1654918719000},"page":"120709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The potential of B7-H6 as a therapeutic target in cancer immunotherapy"],"prefix":"10.1016","volume":"304","author":[{"given":"Alaleh","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souzan","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Mansoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Baghbanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg D.","family":"Hoheisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120709_bb0005","article-title":"Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway","volume":"7","author":"Momtaz","year":"2014","journal-title":"Pharmgenomics. Pers. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0010","doi-asserted-by":"crossref","DOI":"10.4110\/in.2014.14.6.265","article-title":"The CD28-B7 family in anti-tumor immunity: emerging concepts in cancer immunotherapy","volume":"14","author":"Leung","year":"2014","journal-title":"Immune Netw."},{"key":"10.1016\/j.lfs.2022.120709_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2022.120709_bb0020","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-16-0761","article-title":"New B7 family checkpoints in human cancers","volume":"16","author":"Ni","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2022.120709_bb0025","doi-asserted-by":"crossref","DOI":"10.2147\/OTT.S160493","article-title":"Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma","volume":"11","author":"Zhu","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.lfs.2022.120709_bb0030","doi-asserted-by":"crossref","DOI":"10.2174\/1386207320666170315121728","article-title":"The breakthroughs in cancer immune checkpoint based therapy: a review of development in immune checkpoint study and its application","volume":"20","author":"Huang","year":"2017","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.lfs.2022.120709_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2012.04180.x","article-title":"The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells","volume":"12","author":"Magee","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lfs.2022.120709_bb0040","article-title":"The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity","volume":"30","author":"Schnell","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2022.120709_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-065X.2009.00772.x","article-title":"The costimulatory role of TIM molecules","volume":"229","author":"Rodriguez-Manzanet","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2022.120709_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-10-105","article-title":"A fiber-modified adenoviral vector interacts with immunoevasion molecules of the B7 family at the surface of murine leukemia cells derived from dormant tumors","volume":"10","author":"Grellier","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2022.120709_bb0055","article-title":"Expression of a novel immune checkpoint B7\u2013H6 ligand in human small cell lung cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0060","doi-asserted-by":"crossref","DOI":"10.21037\/tcr.2018.07.15","article-title":"Expression and clinical significance of negative costimulatory molecules B7\u2013H1, B7\u2013H3 and B7\u2013H4 in the process of colorectal cancer\u2019s evolution","volume":"7","author":"Qiu","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.lfs.2022.120709_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/protein\/gzx051","article-title":"Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6","volume":"30","author":"Hua","year":"2017","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.lfs.2022.120709_bb0070","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7\u2013H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0897.2010.00841.x","article-title":"B7 family molecules as regulators of the maternal immune system in pregnancy","volume":"63","author":"Petroff","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0080","doi-asserted-by":"crossref","DOI":"10.1007\/s12253-017-0357-5","article-title":"The B7 family member B7\u2013H6: a new bane of tumor","volume":"24","author":"Chen","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.lfs.2022.120709_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2019.12.030","article-title":"Immunological role and underlying mechanisms of B7\u2013H6 in tumorigenesis","volume":"502","author":"Hu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2022.120709_bb0090","doi-asserted-by":"crossref","DOI":"10.29245\/2578-2967\/2019\/4.1171","article-title":"B7 family proteins in cancer progression: immunological and non-immunological functions","volume":"3","author":"Ye","year":"2019","journal-title":"J. Cancer Treat. Diagnosis"},{"key":"10.1016\/j.lfs.2022.120709_bb0095","article-title":"Immune checkpoints of the B7 family. Part 1. General characteristics and first representatives: B7\u20131, B7\u20132, B7\u2013H1, B7\u2013H2, and B7-DC","volume":"45","author":"Chapoval","year":"2019","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.lfs.2022.120709_bb0100","article-title":"Immune checkpoints of the B7 family. Part 2. Representatives of the B7 family B7\u2013H3, B7\u2013H4, B7\u2013H5, B7\u2013H6, B7\u2013H7, and ILDR2 and their receptors","volume":"45","author":"Chapoval","year":"2019","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.lfs.2022.120709_bb0105","doi-asserted-by":"crossref","DOI":"10.4110\/in.2013.13.5.184","article-title":"Emerging co-signaling networks in T cell immune regulation","volume":"13","author":"Jung","year":"2013","journal-title":"Immune Netw."},{"key":"10.1016\/j.lfs.2022.120709_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0609.2012.01766.x","article-title":"The B7 homologues and their receptors in hematologic malignancies","volume":"88","author":"Wilcox","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.lfs.2022.120709_bb0115","article-title":"The regulatory cross-talk between micrornas and novel members of the b7 family in human diseases: a scoping review","volume":"22","author":"Karim Ahangar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120709_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2016.09.011","article-title":"Structural insights into the inhibitory mechanism of an antibody against B7\u2013H6, a stress-induced cellular ligand for the natural killer cell receptor NKp30","volume":"428","author":"Xu","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2022.120709_bb0125","article-title":"Knockdown of B7h6 inhibits tumor progression in triple-negative breast cancer","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2022.120709_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00458","article-title":"The role of B7 family molecules in maternal-fetal immunity","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0135","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2016.3393","article-title":"Knockdown of B7\u2013H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-hodgkin lymphoma","volume":"48","author":"Wu","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2022.120709_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-019-01859-w","article-title":"The integrated stress response promotes B7H6 expression","volume":"98","author":"Obiedat","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.682627","article-title":"B7\u2013H7 is inducible on T cells to regulate their immune response and serves as a marker for exhaustion","volume":"12","author":"Luu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2020.09.019","article-title":"Anti-fouling SERS-based immunosensor for point-of-care detection of the B7\u2013H6 tumor biomarker in cervical cancer patient serum","volume":"1138","author":"Panikar","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.lfs.2022.120709_bb0155","article-title":"B7 family members in lymphoma: promising novel targets for tumor immunotherapy?","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.120709_bb0160","article-title":"Expression of B7\u2013H6 expression in human hepatocellular carcinoma and its clinical significance","volume":"18","author":"Chen","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2022.120709_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201847746","article-title":"B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines","volume":"49","author":"Bj\u00f8rnsen","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0170","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-02-482513","article-title":"Downregulation of the activating NKp30 ligand B7\u2013H6 by HDAC inhibitors impairs tumor cell recognition by NK cells","volume":"122","author":"Fiegler","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2022.120709_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-018-2124-1","article-title":"Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression","volume":"67","author":"Gacerez","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2022.120709_bb0180","doi-asserted-by":"crossref","DOI":"10.1007\/s00251-012-0616-2","article-title":"Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7\u2019s historical relationship with the MHC","volume":"64","author":"Flajnik","year":"2012","journal-title":"Immunogenetics"},{"key":"10.1016\/j.lfs.2022.120709_bb0185","doi-asserted-by":"crossref","DOI":"10.32553\/ijmbs.v3i11.719","article-title":"The immunohistochemical expression of novel B7\u2013H6 in oral squamous cell carcinoma and correlation with histological differentiation and clinicopathological parameters","volume":"3","author":"Fauzia","year":"2019","journal-title":"Int. J. Med. Biomed. Stud."},{"key":"10.1016\/j.lfs.2022.120709_bb0190","article-title":"B7\u2013H6 promotes cell proliferation, migration and invasion of non-hodgkin lymphoma via ras\/MEK\/ERK pathway based on quantitative phosphoproteomics data","volume":"13","author":"Yang","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.lfs.2022.120709_bb0195","doi-asserted-by":"crossref","DOI":"10.1007\/s10637-020-00976-5","article-title":"B7\u2013H6 as an efficient target for T cell-induced cytotoxicity in haematologic malignant cells","volume":"39","author":"Sun","year":"2021","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.lfs.2022.120709_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07608-4","article-title":"B7\u2013H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines","volume":"20","author":"Banu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2022.120709_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s12253-013-9686-1","article-title":"B7\u2013H6 protein expression has no prognostic significance in human gastric carcinoma","volume":"20","author":"Chen","year":"2014","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.lfs.2022.120709_bb0210","article-title":"Clinical significance of B7\u2013H6 protein expression in astrocytoma","volume":"9","author":"Guo","year":"2016","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.lfs.2022.120709_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-020-0341-9","article-title":"Positive staining of the immunoligand B7\u2013H6 in abnormal\/transformed keratinocytes consistently accompanies the progression of cervical cancer","volume":"21","author":"Gutierrez-Silerio","year":"2020","journal-title":"BMC Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/jop.12586","article-title":"The prognostic value of B7\u2013H6 protein expression in human oral squamous cell carcinoma","volume":"46","author":"Wang","year":"2017","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0225","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-10-385591","article-title":"The role of B7 family molecules in hematologic malignancy","volume":"121","author":"Greaves","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2022.120709_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa2327","article-title":"Clinical impact of the NKp30\/B7-H6 axis in high-risk neuroblastoma patients","volume":"7","author":"Semeraro","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0235","article-title":"B7\u2013H6 expression correlates with cancer progression and patient\u2019s survival in human ovarian cancer","volume":"8","author":"Zhou","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.lfs.2022.120709_bb0240","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2017.6417","article-title":"Clinical significance of novel costimulatory molecule b7\u2013h6 in human breast cancer","volume":"14","author":"Sun","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2022.120709_bb0245","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1501102","article-title":"Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production","volume":"196","author":"Salimi","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2328675","article-title":"Preferential expression of B7\u2013H6 in glioma stem-like cells enhances tumor cell proliferation via the c-Myc\/RNMT Axis","volume":"2020","author":"Chen","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.lfs.2022.120709_bb0255","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-011-0802-7","article-title":"B7\u2013H6\/NKp30 interaction: a mechanism of alerting NK cells against tumors","volume":"68","author":"Kaifu","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2022.120709_bb0260","series-title":"B7H6: A Bio-Marker for the Development of Cancer-Targeted Immunotherapy Applications","author":"Phillips","year":"2015"},{"key":"10.1016\/j.lfs.2022.120709_bb0265","article-title":"T lymphocyte co-signaling pathways of the B7-CD28 family","volume":"1","author":"Wang","year":"2004","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0270","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.immunol.20.091101.091806","article-title":"The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses","volume":"20","author":"Carreno","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2013.07.003","article-title":"B7 family checkpoint regulators in immune regulation and disease","volume":"34","author":"Ceeraz","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0280","article-title":"The roles of histone deacetylases and their inhibitors in cancer therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2022.120709_bb0285","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2022.120709_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2013.03.001","article-title":"The SH2 domain interaction landscape","volume":"3","author":"Tinti","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2022.120709_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/bs.acr.2018.02.004","article-title":"Extracellular-regulated kinases: signaling from ras to ERK substrates to control biological outcomes","author":"Eblen","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.lfs.2022.120709_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2010.332","article-title":"Transcriptional upregulation of histone deacetylase 2 promotes myc-induced oncogenic effects","volume":"29","author":"Marshall","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2022.120709_bb0310","doi-asserted-by":"crossref","DOI":"10.1039\/C0IB00046A","article-title":"The origins of cancer robustness and evolvability","volume":"3","author":"Tian","year":"2011","journal-title":"Integr. Biol."},{"key":"10.1016\/j.lfs.2022.120709_bb0315","series-title":"Cancer Biol. How Sci. Work","article-title":"Cancer genomics","author":"Carlberg","year":"2021"},{"key":"10.1016\/j.lfs.2022.120709_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2018.01.001","article-title":"Emerging roles of microRNAs in cancer","volume":"48","author":"Vannini","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.lfs.2022.120709_bb0325","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-32-9717-3_2","article-title":"The CD28\u2013B7 family of co-signaling molecules","author":"Nagai","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2022.120709_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2022.120709_bb0335","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S166584","article-title":"Matrix metalloproteinase 2\/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro\/in vivo studies","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2022.120709_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/07357907.2017.1416393","article-title":"Potential molecular targets in the treatment of lung cancer using siRNA technology","volume":"36","author":"Zarredar","year":"2018","journal-title":"Cancer Investig."},{"key":"10.1016\/j.lfs.2022.120709_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2019.01.028","article-title":"Checkpoint kinase 1 inhibition enhances cisplatin cytotoxicity and overcomes cisplatin resistance in SCLC by promoting mitotic cell death","volume":"14","author":"Hsu","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2022.120709_bb0350","article-title":"Global cancer statistics: 2011","volume":"49","author":"Jemal","year":"1999","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2022.120709_bb0355","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-012-0848-5","article-title":"Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients","volume":"14","author":"Jeremi\u0107","year":"2012","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.lfs.2022.120709_bb0360","article-title":"B7\u2013H6 expression in non-small cell lung cancers","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.lfs.2022.120709_bb0365","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.lfs.2022.120709_bb0370","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2736","article-title":"The globalisation of breast cancer","volume":"12","author":"Boyle","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.lfs.2022.120709_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c3620","article-title":"Disparities in breast cancer mortality trends between 30 european countries: retrospective trend analysis of WHO mortality database","volume":"341","author":"Autier","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.lfs.2022.120709_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2022.120709_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118604","article-title":"Molecular mechanisms of breast cancer chemoresistance by immune checkpoints","volume":"263","author":"Dastmalchi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120709_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118297","article-title":"PD-1\/PD-L1 axis importance and tumor microenvironment immune cells","volume":"259","author":"Lotfinejad","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120709_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.molonc.2010.04.006","article-title":"Triple-negative breast cancer: present challenges and new perspectives","volume":"4","author":"Podo","year":"2010","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lfs.2022.120709_bb0400","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02107-3","article-title":"Triple-negative breast cancer: understanding wnt signaling in drug resistance","volume":"21","author":"Merikhian","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2022.120709_bb0405","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2022.120709_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145376","article-title":"Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer","volume":"772","author":"Amini","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2022.120709_bb0415","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-020-05720-z","article-title":"Current perspectives on the dysregulated microRNAs in gastric cancer","volume":"47","author":"Azarbarzin","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.lfs.2022.120709_bb0420","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2022.120709_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.27015","article-title":"Small interfering RNA\u2013mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma","volume":"234","author":"Hajiasgharzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2022.120709_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.120709_bb0435","article-title":"Induction of apoptosis by a combination of 2-deoxyglucose and metformin in esophageal squamous cell carcinoma by targeting cancer cell metabolism","volume":"44","author":"Shafaee","year":"2019","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.lfs.2022.120709_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54731-9","article-title":"The prognostic value of B7\u2013H6 in esophageal squamous cell carcinoma","volume":"9","author":"Zhou","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.120709_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.609719","article-title":"High expression of tumor abnormal protein preoperatively predicts poor prognosis of patients with esophageal squamous cell carcinoma","volume":"8","author":"Cheng","year":"2021","journal-title":"Front. Surg."},{"key":"10.1016\/j.lfs.2022.120709_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.lfs.2022.120709_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2022.120709_bb0460","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective","volume":"87","author":"Bosch","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2022.120709_bb0465","article-title":"Molecular pathways in the development of hpv-induced cervical cancer","volume":"20","author":"Bonab","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.lfs.2022.120709_bb0470","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-020-05494-4","article-title":"Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer","volume":"47","author":"Hemmat","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.lfs.2022.120709_bb0475","article-title":"Barriers and challenges to treatment alternatives for early-stage cervical cancer in lower-resource settings","volume":"3","author":"Wu","year":"2017","journal-title":"J. Glob. Oncol."},{"key":"10.1016\/j.lfs.2022.120709_bb0480","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2017.6328","article-title":"Expression levels of resistant genes affect cervical cancer prognosis","volume":"15","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2022.120709_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00448","article-title":"Lymphoma immunotherapy: current status","volume":"6","author":"Zappasodi","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0490","article-title":"Stat3 activation and oncogenesis in lymphoma","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2022.120709_bb0495","article-title":"Lymphoma survival patterns by WHO subtype in the United States, 1973\u20132003","volume":"19","author":"Han","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.lfs.2022.120709_bb0500","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2012.080432","article-title":"Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the italian AIEOP and GIMEMA protocols and stratified in age cohorts","volume":"98","author":"Chiaretti","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.lfs.2022.120709_bb0505","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V84.5.1603.1603","article-title":"Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87)","volume":"84","author":"Boucheix","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2022.120709_bb0510","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001\u20132007","volume":"119","author":"Dores","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2022.120709_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00917","article-title":"Current advances in immunotherapy for acute leukemia: an overview of antibody, chimeric antigen receptor, immune checkpoint, and natural killer","volume":"9","author":"Shang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.120709_bb0520","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-5308","article-title":"B7\u2013H6 is a new potential biomarker and therapeutic target of T-lymphoblastic lymphoma","volume":"9","author":"Yuan","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0525","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-10-696054","article-title":"Biology and relevance of human acute myeloid leukemia stem cells","volume":"129","author":"Thomas","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2022.120709_bb0530","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M115.674010","article-title":"Tumor therapeutics work as stress inducers to enhance tumor sensitivity to natural killer (NK) cell cytolysis by up-regulating NKp30 ligand B7\u2013H6","volume":"290","author":"Cao","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120709_bb0535","article-title":"Risk factors of oral cancer in Lahore, Pakistan: a case control design","volume":"29","author":"Fatima","year":"2015","journal-title":"Proc. Shaikh Zayed Postgrad. Med. Inst."},{"key":"10.1016\/j.lfs.2022.120709_bb0540","article-title":"Essentials of oral cancer","volume":"8","author":"Rivera","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.lfs.2022.120709_bb0545","article-title":"Cancer statistics for african americans, 2013","volume":"63","author":"DeSantis","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2022.120709_bb0550","doi-asserted-by":"crossref","DOI":"10.32553\/ijmbs.v3i11.719","article-title":"The immunohistochemical expression of novel B7-H6 in oral squamous cell carcinoma and correlation with histological differentiation and clinicopathological parameters","volume":"3","author":"Fauzia","year":"2019","journal-title":"Int. J. Med. Biomed. Stud."},{"key":"10.1016\/j.lfs.2022.120709_bb0555","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-016-0709-8","article-title":"Current and future strategies for treatment of glioma","volume":"40","author":"Bush","year":"2017","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.lfs.2022.120709_bb0560","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/124.12.2528","article-title":"Brainstem gliomas in adults: prognostic factors and classification","volume":"124","author":"Guillamo","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2022.120709_bb0565","article-title":"High expression of B7\u2013H6 in human glioma tissues promotes tumor progression","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2022.120709_bb0570","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2022.120709_bb0575","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0897.2005.00330.x","article-title":"Regulatory T cells in ovarian cancer: biology and therapeutic potential","volume":"54","author":"Barnett","year":"2005","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0580","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-012-1293-6","article-title":"The expression, function, and clinical relevance of B7 family members in cancer","volume":"61","author":"Seliger","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2022.120709_bb0585","doi-asserted-by":"crossref","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour microenvironment","volume":"8","author":"Zou","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.120709_bb0590","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2010.95","article-title":"Tumor associated endothelial expression of B7\u2013H3 predicts survival in ovarian carcinomas","volume":"23","author":"Zang","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lfs.2022.120709_bb0595","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-07-1866","article-title":"Relationship between B7\u2013H4, regulatory T cells, and patient outcome in human ovarian carcinoma","volume":"67","author":"Kryczek","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2022.120709_bb0600","doi-asserted-by":"crossref","DOI":"10.1177\/1535370219855970","article-title":"Considering B7-CD28 as a family through sequence and structure","volume":"244","author":"West","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2022.120709_bb0605","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-01-481705","article-title":"Induction of B7\u2013H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions","volume":"122","author":"Matta","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2022.120709_bb0610","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.1001224","article-title":"B7\u2013H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape","volume":"4","author":"Pesce","year":"2015","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.lfs.2022.120709_bb0615","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7\u2013H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Cancer Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200409X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200409X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:02:12Z","timestamp":1758402132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052200409X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":123,"alternative-id":["S002432052200409X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120709","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of B7-H6 as a therapeutic target in cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120709"}}